Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
1300 Morris Park Avenue
232 articles about Albert Einstein College of Medicine
Why Do Children Develop Type 2 Diabetes? $4.1 Million NIH Grant Will Help Montefiore Einstein Researchers Investigate
Type 2 diabetes is surging among U.S. children. The number of youths under age 20 living with the disease has nearly doubled between 2001 and 2017, and yet—aside from increases in childhood obesity—the reasons for this disturbing increase are not clear.
Albert Einstein College of Medicine and Montefiore Health System Awarded $30 Million from NIH to Support Its Institute for Clinical and Translational Research
Albert Einstein College of Medicine and Montefiore Health System have received a seven-year, $30 million grant from the National Institutes of Health to continue support for the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore.
Albert Einstein College of Medicine and Montefiore Health System Receive $5.2 Million NIH Grant to Study Heart Failure in Hispanic Populations
Cardiology researchers at Albert Einstein College of Medicine and Montefiore Health System have received a five-year, $5.2 million grant from the National Institutes of Health to explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease.
$11M NIH Grant Will Support Evaluation of Alzheimer's Screening Tool in Primary Care Settings
Investigators at Albert Einstein College of Medicine, Montefiore Health System, Regenstrief Institute, and Indiana University School of Medicine have received an $11 million grant from the National Institutes of Health to evaluate an Einstein-developed test for assessing cognitive impairment and dementia.
Distinguished Cancer and Stem Cell Biologist Ulrich Steidl, M.D., Ph.D., Appointed Chair of Cell Biology at Albert Einstein College of Medicine
Ulrich Steidl, M.D., Ph.D., an internationally recognized leader in cancer and stem cell biology, has been named the chair of the department of cell biology at Albert Einstein College of Medicine.
Albert Einstein College of Medicine Receives $6.6M in NIH Grants to Lead New York Consortium for Kidney, Urological, and Hematological Research and Training
The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $6.6 million grant to lead a New York-based consortium of medical schools to train young scientists in kidney, urology, and hematology research.
Albert Einstein College of Medicine Researchers Develop Promising New Cancer Therapy
Immune checkpoint inhibitors such as Keytruda and Opdivo work by unleashing the immune system's T cells to attack tumor cells.
Einstein Researchers Awarded $3.5 Million NIH Grant to Study Brain Changes Caused by COVID-19
Albert Einstein College of Medicine researchers have been awarded a five-year, $3.5 million grant from the National Institutes of Health to study the effects of COVID-19 on the brains of adults who had mild or asymptomatic infection.
Research Reveals Secrets of Baffling but All-Too-Common Type of Diabetes
A mysterious form of diabetes known as malnutrition-related diabetes afflicts tens of millions of people in Asian and sub-Saharan African countries.
Biohaven Pharma's NDA for its nasal spray zavegepant was accepted by the FDA, while Phase III results for its drug troriluzole to treat spinocerebellar ataxia were disappointing.
Albert Einstein College of Medicine Receives $4.2 Million NIH Grant to Discover Novel Markers of Early Alzheimer's Disease
Diagnosing Alzheimer's disease can be a complex and time-consuming process, requiring evaluations ranging from brain scans to cognitive and lab tests to reviews of medical history and symptoms.
Genetic varations within the human genome is littered with breadcrumbs leading right up to new therapeutic possibilities.
Typical metabolic syndrome treatment includes a healthy diet, exercise, and possibly metformin, but soon, there may be a new treatment. For that and more research news, continue reading.
NCI-Designated Albert Einstein Cancer Center Announces Major Leadership Changes
The National Cancer Institute-designated Albert Einstein Cancer Center has announced the appointment of three faculty members to key leadership positions, reflecting the center's commitment to basic science, translational, and clinical research and its core principles of diversity, equity, and inclusion.
In Cardio Breakthrough, Researchers Prevent Clogged Arteries with Chaperone Mediated Autophagy
3/29/2022New research investigates the role chaperone-mediated autophagy (CMA) can play in preventing atherosclerosis, a thickening or hardening of the arteries.
Researchers at Albert Einstein College of Medicine have cleverly developed a vaccine for pancreatic cancer by using the adaptive immunity already present in nearly all of the global population.
Einstein-Developed Treatment Strategy May Lead to HIV Cure
Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice—offering a path to a functional cure for HIV and other chronic viral infections.
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Einstein College of Medicine to Support Development of Novel Therapeutics
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments, three industry leaders dedicated to the acceleration and growth of innovative healthcare and life science companies, announced the formation of a partnership program with Albert Einstein College of Medicine to support the development of novel therapeutics.
Albert Einstein College of Medicine Receives $4 Million NIH Grant To Support Diabetes Prevention and Management Research
Albert Einstein College of Medicine has received a five-year, $4 million grant from the National Institutes of Health to support the New York Regional Center for Diabetes Translation Research.
Albert Einstein College of Medicine Awarded $5 Million for Research on Intellectual and Developmental Disabilities
Albert Einstein College of Medicine has received a five-year, $5 million grant from the National Institutes of Health to support the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, which has been at the forefront of research on normal and abnormal brain development for more than 50 years.